Coya Therapeutics, Inc.

Coya Therapeutics (Nasdaq: COYA) is a Houston-based clinical-stage biopharmaceutical company developing Treg-targeted therapies for ALS and other neurodegenerative diseases; not the same entity as any of the suggested biotech candidates.